SAN DIEGO, March 6, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI) (www.apricusbio.com) Chief Executive Officer Dr. Bassam Damaj said in an interview on CDTV.net that his company has acquired its own sales force, has nearly $25 million in cash, and is moving in 2012 into a potentially high-growth phase.
